-
1
-
-
34547638047
-
Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer
-
Soda M, Choi YL, Enomoto M, et al. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature 2007;448:561-6.
-
(2007)
Nature
, vol.448
, pp. 561-566
-
-
Soda, M.1
Choi, Y.L.2
Enomoto, M.3
-
2
-
-
80053386829
-
Effect of crizotinib on overall survival in patients with advanced non-smallcell lung cancer harbouring ALK gene rearrangement: a retrospective analysis
-
Shaw AT, Yeap BY, Solomon BJ, et al. Effect of crizotinib on overall survival in patients with advanced non-smallcell lung cancer harbouring ALK gene rearrangement: a retrospective analysis. Lancet Oncol 2011;12:1004-12.
-
(2011)
Lancet Oncol
, vol.12
, pp. 1004-1012
-
-
Shaw, A.T.1
Yeap, B.Y.2
Solomon, B.J.3
-
3
-
-
84868312005
-
Treatment of ALK-positive non-small cell lung cancer
-
Bang YJ. Treatment of ALK-positive non-small cell lung cancer. Arch Pathol Lab Med 2012;136:1201-4.
-
(2012)
Arch Pathol Lab Med
, vol.136
, pp. 1201-1204
-
-
Bang, Y.J.1
-
4
-
-
37549060017
-
EML4-ALK fusion is linked to histological characteristics in a subset of lung cancers
-
Inamura K, Takeuchi K, Togashi Y, et al. EML4-ALK fusion is linked to histological characteristics in a subset of lung cancers. J Thorac Oncol 2008;3:13-7.
-
(2008)
J Thorac Oncol
, vol.3
, pp. 13-17
-
-
Inamura, K.1
Takeuchi, K.2
Togashi, Y.3
-
5
-
-
48249114422
-
EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer
-
Koivunen JP, Mermel C, Zejnullahu K, et al. EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer. Clin Cancer Res 2008;14:4275-83.
-
(2008)
Clin Cancer Res
, vol.14
, pp. 4275-4283
-
-
Koivunen, J.P.1
Mermel, C.2
Zejnullahu, K.3
-
6
-
-
79951769488
-
Screening of anaplastic lymphoma kinase rearrangement by immunohistochemistry in non-small cell lung cancer: correlation with fluorescence in situ hybridization
-
Paik JH, Choe G, Kim H, et al. Screening of anaplastic lymphoma kinase rearrangement by immunohistochemistry in non-small cell lung cancer: correlation with fluorescence in situ hybridization. J Thorac Oncol 2011;6:466-72.
-
(2011)
J Thorac Oncol
, vol.6
, pp. 466-472
-
-
Paik, J.H.1
Choe, G.2
Kim, H.3
-
7
-
-
63949087355
-
EML4-ALK lung cancers are characterized by rare other mutations, a TTF-1 cell lineage, an acinar histology, and young onset
-
Inamura K, Takeuchi K, Togashi Y, et al. EML4-ALK lung cancers are characterized by rare other mutations, a TTF-1 cell lineage, an acinar histology, and young onset. Mod Pathol 2009;22:508-15.
-
(2009)
Mod Pathol
, vol.22
, pp. 508-515
-
-
Inamura, K.1
Takeuchi, K.2
Togashi, Y.3
-
8
-
-
70349336416
-
Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK
-
Shaw AT, Yeap BY, Mino-Kenudson M, et al. Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK. J Clin Oncol 2009;27:4247-53.
-
(2009)
J Clin Oncol
, vol.27
, pp. 4247-4253
-
-
Shaw, A.T.1
Yeap, B.Y.2
Mino-Kenudson, M.3
-
9
-
-
69349083935
-
Unique clinicopathologic features characterize ALK-rearranged lung adenocarcinoma in the western population
-
Rodig SJ, Mino-Kenudson M, Dacic S, et al. Unique clinicopathologic features characterize ALK-rearranged lung adenocarcinoma in the western population. Clin Cancer Res 2009;15:5216-23.
-
(2009)
Clin Cancer Res
, vol.15
, pp. 5216-5223
-
-
Rodig, S.J.1
Mino-Kenudson, M.2
Dacic, S.3
-
10
-
-
79955467025
-
Frequent ALK rearrangement and TTF-1/p63 co-expression in lung adenocarcinoma with signet-ring cell component
-
Yoshida A, Tsuta K, Watanabe S, et al. Frequent ALK rearrangement and TTF-1/p63 co-expression in lung adenocarcinoma with signet-ring cell component. Lung Cancer 2011;72:309-15.
-
(2011)
Lung Cancer
, vol.72
, pp. 309-315
-
-
Yoshida, A.1
Tsuta, K.2
Watanabe, S.3
-
11
-
-
79961099514
-
Comprehensive histologic analysis of ALK-rearranged lung carcinomas
-
Yoshida A, Tsuta K, Nakamura H, et al. Comprehensive histologic analysis of ALK-rearranged lung carcinomas. Am J Surg Pathol 2011;35:1226-34.
-
(2011)
Am J Surg Pathol
, vol.35
, pp. 1226-1234
-
-
Yoshida, A.1
Tsuta, K.2
Nakamura, H.3
-
12
-
-
84868459016
-
Histologic and cytomorphologic features of ALK-rearranged lung adenocarcinomas
-
Nishino M, Klepeis VE, Yeap BY, et al. Histologic and cytomorphologic features of ALK-rearranged lung adenocarcinomas. Mod Pathol 2012;25:1462-72.
-
(2012)
Mod Pathol
, vol.25
, pp. 1462-1472
-
-
Nishino, M.1
Klepeis, V.E.2
Yeap, B.Y.3
-
13
-
-
79551563284
-
International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma
-
Travis WD, Brambilla E, Noguchi M, et al. International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 2011;6:244-85.
-
(2011)
J Thorac Oncol
, vol.6
, pp. 244-285
-
-
Travis, W.D.1
Brambilla, E.2
Noguchi, M.3
-
14
-
-
84899477450
-
An international interpretation study using the ALK IHC antibody D5F3 and a sensitive detection kit demonstrates high concordance between ALK IHC and ALK FISH and between evaluators
-
Wynes MW, Sholl LM, Dietel M, et al. An international interpretation study using the ALK IHC antibody D5F3 and a sensitive detection kit demonstrates high concordance between ALK IHC and ALK FISH and between evaluators. J Thorac Oncol 2014;9:631-8.
-
(2014)
J Thorac Oncol
, vol.9
, pp. 631-638
-
-
Wynes, M.W.1
Sholl, L.M.2
Dietel, M.3
-
15
-
-
36849065315
-
Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer
-
Rikova K, Guo A, Zeng Q, et al. Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. Cell 2007;131:1190-203.
-
(2007)
Cell
, vol.131
, pp. 1190-1203
-
-
Rikova, K.1
Guo, A.2
Zeng, Q.3
-
16
-
-
63949086127
-
KIF5BALK, a novel fusion oncokinase identified by an immunohistochemistry-based diagnostic system for ALKpositive lung cancer
-
Takeuchi K, Choi YL, Togashi Y, et al. KIF5BALK, a novel fusion oncokinase identified by an immunohistochemistry-based diagnostic system for ALKpositive lung cancer. Clin Cancer Res 2009;15:3143-9.
-
(2009)
Clin Cancer Res
, vol.15
, pp. 3143-3149
-
-
Takeuchi, K.1
Choi, Y.L.2
Togashi, Y.3
-
17
-
-
84856695102
-
KLC1-ALK: a novel fusion in lung cancer identified using a formalin-fixed paraffin-embedded tissue only
-
Togashi Y, Soda M, Sakata S, et al. KLC1-ALK: a novel fusion in lung cancer identified using a formalin-fixed paraffin-embedded tissue only. PLoS One 2012;7:e31323.
-
(2012)
PLoS One
, vol.7
-
-
Togashi, Y.1
Soda, M.2
Sakata, S.3
-
18
-
-
48549098388
-
Identification of novel isoforms of the EML4-ALK transforming gene in non-small cell lung cancer
-
Choi YL, Takeuchi K, Soda M, et al. Identification of novel isoforms of the EML4-ALK transforming gene in non-small cell lung cancer. Cancer Res 2008;68:4971-6.
-
(2008)
Cancer Res
, vol.68
, pp. 4971-4976
-
-
Choi, Y.L.1
Takeuchi, K.2
Soda, M.3
-
19
-
-
57349113565
-
Multiplex reverse transcription-PCR screening for EML4-ALK fusion transcripts
-
Takeuchi K, Choi YL, Soda M, et al. Multiplex reverse transcription-PCR screening for EML4-ALK fusion transcripts. Clin Cancer Res 2008;14:6618-24.
-
(2008)
Clin Cancer Res
, vol.14
, pp. 6618-6624
-
-
Takeuchi, K.1
Choi, Y.L.2
Soda, M.3
-
20
-
-
79955656623
-
Exon scanning by reverse transcriptase-polymerase chain reaction for detection of known and novel EML4-ALK fusion variants in non-small cell lung cancer
-
Sanders HR, Li HR, Bruey JM, et al. Exon scanning by reverse transcriptase-polymerase chain reaction for detection of known and novel EML4-ALK fusion variants in non-small cell lung cancer. Cancer Genet 2011;204:45-52.
-
(2011)
Cancer Genet
, vol.204
, pp. 45-52
-
-
Sanders, H.R.1
Li, H.R.2
Bruey, J.M.3
-
21
-
-
65249095599
-
The EML4-ALK fusion gene is involved in various histologic types of lung cancers from nonsmokers with wild-type EGFR and KRAS
-
Wong DW, Leung EL, So KK, et al. The EML4-ALK fusion gene is involved in various histologic types of lung cancers from nonsmokers with wild-type EGFR and KRAS. Cancer 2009;115:1723-33.
-
(2009)
Cancer
, vol.115
, pp. 1723-1733
-
-
Wong, D.W.1
Leung, E.L.2
So, K.K.3
-
22
-
-
84865845420
-
EML4-ALK rearrangement and its clinical significance in Chinese patients with advanced non-small cell lung cancer
-
Wang Z, Zhang X, Bai H, et al. EML4-ALK rearrangement and its clinical significance in Chinese patients with advanced non-small cell lung cancer. Oncology 2012;83:248-56.
-
(2012)
Oncology
, vol.83
, pp. 248-256
-
-
Wang, Z.1
Zhang, X.2
Bai, H.3
-
23
-
-
84872330303
-
Clinical significance of EML4-ALK fusion gene and association with EGFR and KRAS gene mutations in 208 Chinese patients with non-small cell lung cancer
-
Li Y, Li Y, Yang T, et al. Clinical significance of EML4-ALK fusion gene and association with EGFR and KRAS gene mutations in 208 Chinese patients with non-small cell lung cancer. PLoS One 2013;8:e52093.
-
(2013)
PLoS One
, vol.8
-
-
Li, Y.1
Li, Y.2
Yang, T.3
-
24
-
-
79955482290
-
Clinicopathologic characteristics and outcomes of patients with anaplastic lymphoma kinase-positive advanced pulmonary adenocarcinoma: suggestion for an effective screening strategy for these tumors
-
Koh Y, Kim DW, Kim TM, et al. Clinicopathologic characteristics and outcomes of patients with anaplastic lymphoma kinase-positive advanced pulmonary adenocarcinoma: suggestion for an effective screening strategy for these tumors. J Thorac Oncol 2011;6:905-12.
-
(2011)
J Thorac Oncol
, vol.6
, pp. 905-912
-
-
Koh, Y.1
Kim, D.W.2
Kim, T.M.3
-
25
-
-
84885996181
-
A comprehensive comparative analysis of the histomorphological features of ALK-rearranged lung adenocarcinoma based on driver oncogene mutations: frequent expression of epithelialmesenchymal transition markers than other genotype
-
Kim H, Jang SJ, Chung DH, et al. A comprehensive comparative analysis of the histomorphological features of ALK-rearranged lung adenocarcinoma based on driver oncogene mutations: frequent expression of epithelialmesenchymal transition markers than other genotype. PLoS One 2013;8:e76999.
-
(2013)
PLoS One
, vol.8
-
-
Kim, H.1
Jang, S.J.2
Chung, D.H.3
-
26
-
-
84860500563
-
Clinicopathologic implication of ALK rearrangement in surgically resected lung cancer: a proposal of diagnostic algorithm for ALKrearranged adenocarcinoma
-
Paik JH, Choi CM, Kim H, et al. Clinicopathologic implication of ALK rearrangement in surgically resected lung cancer: a proposal of diagnostic algorithm for ALKrearranged adenocarcinoma. Lung Cancer 2012;76:403-9.
-
(2012)
Lung Cancer
, vol.76
, pp. 403-409
-
-
Paik, J.H.1
Choi, C.M.2
Kim, H.3
-
27
-
-
84905485589
-
Simultaneous diagnostic platform of genotyping EGFR, KRAS, and ALK in 510 Korean patients with non-small-cell lung cancer highlights significantly higher ALK rearrangement rate in advanced stage
-
Kim TJ, Park CK, Yeo CD, et al. Simultaneous diagnostic platform of genotyping EGFR, KRAS, and ALK in 510 Korean patients with non-small-cell lung cancer highlights significantly higher ALK rearrangement rate in advanced stage. J Surg Oncol 2014;110:245-51.
-
(2014)
J Surg Oncol
, vol.110
, pp. 245-251
-
-
Kim, T.J.1
Park, C.K.2
Yeo, C.D.3
-
28
-
-
84856571417
-
ALK translocation is associated with ALK immunoreactivity and extensive signet-ring morphology in primary lung adenocarcinoma
-
Popat S, Gonzalez D, Min T, et al. ALK translocation is associated with ALK immunoreactivity and extensive signet-ring morphology in primary lung adenocarcinoma. Lung Cancer 2012;75:300-5.
-
(2012)
Lung Cancer
, vol.75
, pp. 300-305
-
-
Popat, S.1
Gonzalez, D.2
Min, T.3
-
29
-
-
34247172606
-
Epidermal growth factor receptor mutations in lung cancers
-
Yatabe Y, Mitsudomi T. Epidermal growth factor receptor mutations in lung cancers. Pathol Int 2007;57:233-44.
-
(2007)
Pathol Int
, vol.57
, pp. 233-244
-
-
Yatabe, Y.1
Mitsudomi, T.2
-
30
-
-
17744371335
-
EGFR mutation is specific for terminal respiratory unit type adenocarcinoma
-
Yatabe Y, Kosaka T, Takahashi T, et al. EGFR mutation is specific for terminal respiratory unit type adenocarcinoma. Am J Surg Pathol 2005;29:633-9.
-
(2005)
Am J Surg Pathol
, vol.29
, pp. 633-639
-
-
Yatabe, Y.1
Kosaka, T.2
Takahashi, T.3
-
32
-
-
42549103131
-
Immunohistochemical detection of XIAP and p63 in adenomatous hyperplasia, atypical adenomatous hyperplasia, bronchioloalveolar carcinoma and well-differentiated adenocarcinoma
-
Wu M, Orta L, Gil J, et al. Immunohistochemical detection of XIAP and p63 in adenomatous hyperplasia, atypical adenomatous hyperplasia, bronchioloalveolar carcinoma and well-differentiated adenocarcinoma. Mod Pathol 2008;21:553-8.
-
(2008)
Mod Pathol
, vol.21
, pp. 553-558
-
-
Wu, M.1
Orta, L.2
Gil, J.3
-
33
-
-
84879307418
-
ALK rearrangement in a pure squamous cell carcinoma: the challenge of detection of ALK rearrangement
-
Kim H, Park E, Kim YJ, et al. ALK rearrangement in a pure squamous cell carcinoma: the challenge of detection of ALK rearrangement. Virchows Arch 2013;462:597-9.
-
(2013)
Virchows Arch
, vol.462
, pp. 597-599
-
-
Kim, H.1
Park, E.2
Kim, Y.J.3
-
34
-
-
84907344288
-
Oncogenic mutations are associated with histological subtypes but do not have an independent prognostic value in lung adenocarcinoma
-
Hu H, Pan Y, Li Y, et al. Oncogenic mutations are associated with histological subtypes but do not have an independent prognostic value in lung adenocarcinoma. Onco Targets Ther 2014;7:1423-37.
-
(2014)
Onco Targets Ther
, vol.7
, pp. 1423-1437
-
-
Hu, H.1
Pan, Y.2
Li, Y.3
-
35
-
-
84871986190
-
Immunohistochemistry is a reliable screening tool for identification of ALK rearrangement in non-small-cell lung carcinoma and is antibody dependent
-
Conklin CM, Craddock KJ, Have C, et al. Immunohistochemistry is a reliable screening tool for identification of ALK rearrangement in non-small-cell lung carcinoma and is antibody dependent. J Thorac Oncol 2013;8:45-51.
-
(2013)
J Thorac Oncol
, vol.8
, pp. 45-51
-
-
Conklin, C.M.1
Craddock, K.J.2
Have, C.3
-
36
-
-
77649091118
-
A novel, highly sensitive antibody allows for the routine detection of ALK-rearranged lung adenocarcinomas by standard immunohistochemistry
-
Mino-Kenudson M, Chirieac LR, Law K, et al. A novel, highly sensitive antibody allows for the routine detection of ALK-rearranged lung adenocarcinomas by standard immunohistochemistry. Clin Cancer Res 2010;16:1561-71.
-
(2010)
Clin Cancer Res
, vol.16
, pp. 1561-1571
-
-
Mino-Kenudson, M.1
Chirieac, L.R.2
Law, K.3
-
37
-
-
84889078337
-
Testing for ALK rearrangement in lung adenocarcinoma: a multicenter comparison of immunohistochemistry and fluorescent in situ hybridization
-
Selinger CI, Rogers TM, Russell PA, et al. Testing for ALK rearrangement in lung adenocarcinoma: a multicenter comparison of immunohistochemistry and fluorescent in situ hybridization. Mod Pathol 2013;26:1545-53.
-
(2013)
Mod Pathol
, vol.26
, pp. 1545-1553
-
-
Selinger, C.I.1
Rogers, T.M.2
Russell, P.A.3
-
38
-
-
84876482049
-
ALK status testing in non-small cell lung carcinoma: correlation between ultrasensitive IHC and FISH
-
Minca EC, Portier BP, Wang Z, et al. ALK status testing in non-small cell lung carcinoma: correlation between ultrasensitive IHC and FISH. J Mol Diagn 2013;15:341-6.
-
(2013)
J Mol Diagn
, vol.15
, pp. 341-346
-
-
Minca, E.C.1
Portier, B.P.2
Wang, Z.3
-
39
-
-
84884730006
-
Diagnostic value of a novel fully automated immunochemistry assay for detection of ALK rearrangement in primary lung adenocarcinoma
-
Ying J, Guo L, Qiu T, et al. Diagnostic value of a novel fully automated immunochemistry assay for detection of ALK rearrangement in primary lung adenocarcinoma. Ann Oncol 2013;24:2589-93.
-
(2013)
Ann Oncol
, vol.24
, pp. 2589-2593
-
-
Ying, J.1
Guo, L.2
Qiu, T.3
-
40
-
-
84922691277
-
ALK Rearrangement in a Large Series of Consecutive Non-Small Cell Lung Cancers: Comparison Between a New Immunohistochemical Approach and Fluorescence In Situ Hybridization for the Screening of Patients Eligible for Crizotinib Treatment
-
Alì G, Proietti A, Pelliccioni S, et al. ALK Rearrangement in a Large Series of Consecutive Non-Small Cell Lung Cancers: Comparison Between a New Immunohistochemical Approach and Fluorescence In Situ Hybridization for the Screening of Patients Eligible for Crizotinib Treatment. Arch Pathol Lab Med 2014;138:1449-58.
-
(2014)
Arch Pathol Lab Med
, vol.138
, pp. 1449-1458
-
-
Alì, G.1
Proietti, A.2
Pelliccioni, S.3
-
41
-
-
84880917028
-
Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology
-
Lindeman NI, Cagle PT, Beasley MB, et al. Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology. J Thorac Oncol 2013;8:823-59.
-
(2013)
J Thorac Oncol
, vol.8
, pp. 823-859
-
-
Lindeman, N.I.1
Cagle, P.T.2
Beasley, M.B.3
-
42
-
-
79951774364
-
Correlation of IHC and FISH for ALK gene rearrangement in non-small cell lung carcinoma: IHC score algorithm for FISH
-
Yi ES, Boland JM, Maleszewski JJ, et al. Correlation of IHC and FISH for ALK gene rearrangement in non-small cell lung carcinoma: IHC score algorithm for FISH. J Thorac Oncol 2011;6:459-65.
-
(2011)
J Thorac Oncol
, vol.6
, pp. 459-465
-
-
Yi, E.S.1
Boland, J.M.2
Maleszewski, J.J.3
-
43
-
-
84885581991
-
Immunohistochemistry reliably detects ALK rearrangements in patients with advanced non-small-cell lung cancer
-
Han XH, Zhang NN, Ma L, et al. Immunohistochemistry reliably detects ALK rearrangements in patients with advanced non-small-cell lung cancer. Virchows Arch 2013;463:583-91.
-
(2013)
Virchows Arch
, vol.463
, pp. 583-591
-
-
Han, X.H.1
Zhang, N.N.2
Ma, L.3
-
44
-
-
84872854915
-
Fluorescence in situ hybridization and immunohistochemistry as diagnostic methods for ALK positive non-small cell lung cancer patients
-
Martinez P, Hernández-Losa J, Montero Má, et al. Fluorescence in situ hybridization and immunohistochemistry as diagnostic methods for ALK positive non-small cell lung cancer patients. PLoS One 2013;8:e52261.
-
(2013)
PLoS One
, vol.8
-
-
Martinez, P.1
Hernández-Losa, J.2
Montero, Má.3
-
45
-
-
84857781304
-
Dual IHC and FISH testing for ALK gene rearrangement in lung adenocarcinomas in a routine practice: a French study
-
McLeer-Florin A, Moro-Sibilot D, Melis A, et al. Dual IHC and FISH testing for ALK gene rearrangement in lung adenocarcinomas in a routine practice: a French study. J Thorac Oncol 2012;7:348-54.
-
(2012)
J Thorac Oncol
, vol.7
, pp. 348-354
-
-
McLeer-Florin, A.1
Moro-Sibilot, D.2
Melis, A.3
-
46
-
-
84856990335
-
Mechanisms of resistance to crizotinib in patients with ALK gene rearranged non-small cell lung cancer
-
Doebele RC, Pilling AB, Aisner DL, et al. Mechanisms of resistance to crizotinib in patients with ALK gene rearranged non-small cell lung cancer. Clin Cancer Res 2012;18:1472-82.
-
(2012)
Clin Cancer Res
, vol.18
, pp. 1472-1482
-
-
Doebele, R.C.1
Pilling, A.B.2
Aisner, D.L.3
-
47
-
-
84875396927
-
Heterogeneity of genetic changes associated with acquired crizotinib resistance in ALK-rearranged lung cancer
-
Kim S, Kim TM, Kim DW, et al. Heterogeneity of genetic changes associated with acquired crizotinib resistance in ALK-rearranged lung cancer. J Thorac Oncol 2013;8:415-22.
-
(2013)
J Thorac Oncol
, vol.8
, pp. 415-422
-
-
Kim, S.1
Kim, T.M.2
Kim, D.W.3
-
48
-
-
78049426513
-
EML4-ALK mutations in lung cancer that confer resistance to ALK inhibitors
-
Choi YL, Soda M, Yamashita Y, et al. EML4-ALK mutations in lung cancer that confer resistance to ALK inhibitors. N Engl J Med 2010;363:1734-9.
-
(2010)
N Engl J Med
, vol.363
, pp. 1734-1739
-
-
Choi, Y.L.1
Soda, M.2
Yamashita, Y.3
-
49
-
-
79953118839
-
Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors
-
Sequist LV, Waltman BA, Dias-Santagata D, et al. Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors. Sci Transl Med 2011;3:75ra26.
-
(2011)
Sci Transl Med
, vol.3
-
-
Sequist, L.V.1
Waltman, B.A.2
Dias-Santagata, D.3
-
50
-
-
84930538309
-
Rebiopsy during disease progression in patients treated by TKI for oncogene-addicted NSCLC
-
[Epub ahead of print]
-
Bosc C, Ferretti GR, Cadranel J, et al. Rebiopsy during disease progression in patients treated by TKI for oncogene-addicted NSCLC. Target Oncol 2014. [Epub ahead of print].
-
(2014)
Target Oncol
-
-
Bosc, C.1
Ferretti, G.R.2
Cadranel, J.3
-
51
-
-
79952259564
-
Rebiopsy of lung cancer patients with acquired resistance to EGFR inhibitors and enhanced detection of the T790M mutation using a locked nucleic acid-based assay
-
Arcila ME, Oxnard GR, Nafa K, et al. Rebiopsy of lung cancer patients with acquired resistance to EGFR inhibitors and enhanced detection of the T790M mutation using a locked nucleic acid-based assay. Clin Cancer Res 2011;17:1169-80.
-
(2011)
Clin Cancer Res
, vol.17
, pp. 1169-1180
-
-
Arcila, M.E.1
Oxnard, G.R.2
Nafa, K.3
-
52
-
-
84871135647
-
Discordance between anaplastic lymphoma kinase status in primary non-smallcell lung cancers and their corresponding metastases
-
Kim H, Xu X, Yoo SB, et al. Discordance between anaplastic lymphoma kinase status in primary non-smallcell lung cancers and their corresponding metastases. Histopathology 2013;62:305-14.
-
(2013)
Histopathology
, vol.62
, pp. 305-314
-
-
Kim, H.1
Xu, X.2
Yoo, S.B.3
-
53
-
-
84896719958
-
Success and failure rates of tumor genotyping techniques in routine pathological samples with non-small-cell lung cancer
-
Vanderlaan PA, Yamaguchi N, Folch E, et al. Success and failure rates of tumor genotyping techniques in routine pathological samples with non-small-cell lung cancer. Lung Cancer 2014;84:39-44.
-
(2014)
Lung Cancer
, vol.84
, pp. 39-44
-
-
Vanderlaan, P.A.1
Yamaguchi, N.2
Folch, E.3
-
54
-
-
84880312534
-
Analysis of the effect of various decalcification agents on the quantity and quality of nucleic acid (DNA and RNA) recovered from bone biopsies
-
Singh VM, Salunga RC, Huang VJ, et al. Analysis of the effect of various decalcification agents on the quantity and quality of nucleic acid (DNA and RNA) recovered from bone biopsies. Ann Diagn Pathol 2013;17:322-6.
-
(2013)
Ann Diagn Pathol
, vol.17
, pp. 322-326
-
-
Singh, V.M.1
Salunga, R.C.2
Huang, V.J.3
|